Edition:
United Kingdom

GenMark Diagnostics Inc (GNMK.OQ)

GNMK.OQ on NASDAQ Stock Exchange Global Market

5.89USD
22 Oct 2018
Change (% chg)

$0.05 (+0.86%)
Prev Close
$5.84
Open
$5.84
Day's High
$5.93
Day's Low
$5.77
Volume
46,998
Avg. Vol
72,165
52-wk High
$8.81
52-wk Low
$3.63

Latest Key Developments (Source: Significant Developments)

GenMark Diagnostics Says Co Entered Into Sixth Amendment To Loan And Security Agreement With Solar Senior Capital & Other Lenders
Thursday, 4 Oct 2018 

Oct 4 (Reuters) - GenMark Diagnostics Inc ::GENMARK DIAGNOSTICS SAYS ON SEPT 28, CO ENTERED INTO SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT WITH SOLAR SENIOR CAPITAL & OTHER LENDERS.GENMARK DIAGNOSTICS -AMENDMENT EXTENDS INTEREST-ONLY PERIOD IN RESPECT OF AMOUNTS BORROWED UNDER AGREEMENT UNTIL JAN 1, 2020- SEC FILING.GENMARK DIAGNOSTICS - AGREEMENT ALSO EXTENDS FINAL MATURITY DATE ON WHICH ALL OF CO'S LIABILITIES UNDER AGREEMENT BECOME DUE UNTIL JAN 1, 2021.  Full Article

Genmark Diagnostics Announces FDA Submission Of Its ePlex Blood Culture Identification Gram Positive Panel
Thursday, 28 Jun 2018 

June 28 (Reuters) - GenMark Diagnostics Inc ::GENMARK DIAGNOSTICS ANNOUNCES FDA SUBMISSION OF ITS EPLEX BLOOD CULTURE IDENTIFICATION GRAM POSITIVE PANEL.GENMARK DIAGNOSTICS INC - ANTICIPATES FDA SUBMISSION OF GRAM NEGATIVE PANEL (BCID-GN) AND FUNGAL PATHOGEN PANEL (BCID-FP) IN Q3 AND Q4 THIS YEAR.  Full Article

GenMark Diagnostics Sees Q4 2017 Revenue About $16 Mln
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Genmark Diagnostics Inc ::GENMARK DIAGNOSTICS PROVIDES PRELIMINARY OPERATIONAL AND FINANCIAL RESULTS FOR 2017.SEES FY 2017 REVENUE ABOUT $52.5 MILLION.SEES Q4 2017 REVENUE ABOUT $16 MILLION.SEES FY 2017 REVENUE UP 7 PERCENT.SEES Q4 2017 REVENUE UP 8 PERCENT.Q4 REVENUE VIEW $15.2 MILLION -- THOMSON REUTERS I/B/E/S.FY2017 REVENUE VIEW $51.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Genmark Diagnostics Entered Fifth Amendment To Loan And Security Agreement
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Genmark Diagnostics Inc ::GENMARK DIAGNOSTICS INC - ON DEC 13 CO ENTERED FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT WITH SOLAR SENIOR CAPITAL - SEC FILING.GENMARK DIAGNOSTICS INC - AS PER AMENDMENT, MATURITY DATE FOR LOAN AND SECURITY AGREEMENT EXTENDED TO MARCH 12, 2020.  Full Article

Genmark Diagnostics Q3 loss per share $0.28
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Genmark Diagnostics Inc :Genmark diagnostics reports third quarter 2017 results.Q3 loss per share $0.28.Q3 revenue rose 7.3 percent to $11.6 million.Q3 revenue view $14.6 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue $51 million to $53 million.  Full Article